Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteins. - Leach, Adam; Miller, Ami; Bentley, Emma; Mattiuzzo, Giada; Thomas, Jemima; McAndrew, Craig; Van Montfort, Rob; Rabbitts, Terence (Scientific Reports, 2021)